Gucci Beauty could become L'Oréal's next billion-euro brand

Overview

This report focuses on L'Oréal's growth potential after acquiring long-term beauty licenses for brands including Gucci through the Kering Beauté transaction. Goldman Sachs views Gucci Beauty as the core strategic asset of the transaction. L'Oréal has successfully scaled the beauty businesses of fashion brands such as YSL, Armani, Valentino, and Prada in the luxury beauty market, giving Gucci the potential to become the next billion-euro or even multi-billion-euro beauty brand.

Core views

The core views are: first, the early redemption of the Gucci license allows L'Oréal to take control of the brand development pace sooner; second, L'Oréal Luxe has a strong execution track record, with YSL Beauty growing from approximately €300 million to more than €3 billion, demonstrating that the business model of developing beauty businesses from high-end fashion brands has been validated; third, Gucci Beauty's current sales of approximately €500 million still leave significant room for growth; and fourth, the transaction-related cash outlay is manageable relative to L'Oréal's balance sheet and does not change the Buy rating.

Analysis framework

The report combines brand case-study comparisons, segment growth analysis, earnings forecasts, valuation models, and risk assessment. At the brand level, it uses historical L'Oréal Luxe cases such as YSL, Prada, Valentino, and Armani as references; financially, it assesses the impact of bringing Gucci onto the accounts early on FY27 forecasts, organic sales growth, and the balance sheet; for valuation, it uses a blended approach based on DCF and P/E multiples.

Methodology notes

• Valuation methodsBlended DCF and Multiple Valuation

  The target price is derived using a 50/50 weighting of DCF and P/E multiples

  The DCF assumes a WACC of 7.1% and a terminal growth rate of 2.5%, implying an intrinsic value of €441 per share; the multiple method applies a 28x P/E to Q5-Q8 EPS, implying €434 per share, which is rounded to a €435 target price.

• Factor AnalysisGS Factor Profile

  Comparison of growth, financial returns, valuation multiples, and composite factors

  The Goldman Sachs factor framework compares the stock with the coverage universe and industry peers, using sales, EBITDA, and EPS growth; ROE, ROCE, and CROCI; and metrics including P/E, P/B, and EV/EBITDA to form percentile rankings.

• M&A ScenarioM&A Rank

  Measures the probability of a company becoming an acquisition target on a scale of 1 to 3

  Goldman Sachs states that it uses qualitative and quantitative factors to assess M&A potential across its global coverage; Rank 1 represents a 30%-50% probability, Rank 2 represents 15%-30%, and Rank 3 represents 0%-15%.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• L'Oréal (OREP.PA)

  Research subject and Buy-rated stock

  Strengths

  Strong track record in operating luxury beauty brands, a robust balance sheet, and long-term growth capabilities at L'Oréal Luxe above the market rate.

  Weaknesses

  L'Oréal Luxe's margin has been under pressure since FY23, while growth has been weaker in some regions, such as North Asia and Latin America.

  Comparison

  YSL Beauty grew from approximately €300 million to more than €3 billion, Prada grew 3.5x from 2021 to 2024, and Valentino grew from below €50 million in 2019 to approximately €600 million, providing comparable cases for Gucci.

  Risks

  Slower-than-expected recovery in China, a slowdown in U.S. beauty demand, share loss caused by digital channels lowering barriers to entry, and foreign-exchange volatility.

• Gucci Beauty

  Potential growth asset and new license opportunity

  Strengths

  High Gucci brand awareness and significant room for growth from its current sales scale of approximately €500 million relative to cases such as YSL.

  Weaknesses

  The early redemption of the license still requires regulatory approval, and the inventory purchase amount has not been disclosed.

  Comparison

  The report compares Gucci with Couture brands successfully operated by L'Oréal, including YSL, Armani, Valentino, and Prada.

  Risks

  Execution of brand integration falling short of expectations, a slowdown in luxury beauty market growth, and uncertainty regarding regulatory approval and redemption costs.

Key data

• RatingBUYThe rating has been Buy since September 29, 2020.
• 12-month target price€435Derived using a 50/50 weighting of the DCF and multiple methods.
• Estimated Gucci Beauty salesapproximately €500 millionGoldman Sachs estimate, used as the basis for the growth opportunity analysis.
• FY27 pro forma impactapproximately +0.5%Pro forma uplift to FY27 estimates from the early redemption, excluding the impact of inventory purchases.
• Potential organic growth contributionapproximately 50 basis pointsThe report believes that the Gucci license could help L'Oréal approach medium-term organic sales growth of 6% over the coming years.
• Q2 adjusted organic sales growth forecast5.8%Slightly above the company's aggregated consensus of 5.6%.
• FY26E net debt/EBITDA0.7xUsed to support the view that the transaction payment burden is manageable.
• L'Oréal Luxe share of group sales35%Based on the 2025 segment sales chart.
• Change in fragrance sales scale3.5x FY25 versus FY10The report highlights fragrance as a growth driver for luxury beauty.
• Fragrance share of group sales15%Up from 9% in FY10.

Impact & implications

If L'Oréal successfully replicates the beauty scaling trajectory of brands such as YSL, Gucci Beauty could become an important source of incremental growth for L'Oréal Luxe over the coming years and amplify the group's growth leverage in luxury fragrance and high-end beauty. For investors, the short-term focus is whether Q2 results support the 5.8% growth expectation; over the medium term, attention should turn to Gucci integration, luxury beauty growth, and demand recovery in China and the United States.

Risks

• China's recovery is slower than expected following changes to Daigou policies.
• Macroeconomic pressure or shifts in consumer trends weaken the U.S. beauty market.
• Digital channels lower industry barriers to entry, potentially resulting in L'Oréal market share loss.
• Foreign-exchange volatility and changes in overall consumer demand in key markets.
• The early redemption of the Gucci license still requires customary regulatory approval, and inventory purchase costs have not been disclosed.

What to watch

• Whether L'Oréal's Q2 results, scheduled for release on July 29, deliver the expected 5.8% organic sales growth.
• Progress on regulatory approval and the final economic terms of the early redemption of the Gucci license.
• Whether L'Oréal Luxe can return to high-single-digit growth.
• Whether the fragrance business continues to grow at two to three times the market rate.
• Divergence in growth across China, North America, North Asia, Latin America, and SAPMENA-SSA.
• Whether the group's H1 EBIT margin remains flat year over year.